Dr. Mark Sunung Khil, MD

Dr. Khil practices at Blessing Hospital in Quincy, Illinois, part of Blessing Health System.

Dr. Khil's NPI, 1851398598, was assigned on July 7, 2005. Dr. Khil holds Illinois license 036105011.

Dr. Khil's primary practice is Blessing Hospital, at 1005 Broadway St, Quincy, IL 62301 in Adams County. The practice phone is (217) 223-1200.

Dr. Khil's primary practice is Blessing Hospital in Quincy, Illinois, part of Blessing Health System. Dr. Khil is also affiliated with Javon Bea Hospital-Riverside. The medical group on file is Blessing Hospital. Dmand AI also links Dr. Khil to 1 more medical group, named with a free account. Dr. Khil's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khil practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Khil's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Khil is licensed in Illinois.

CMS data shows 880 Medicare services from Dr. Khil across 12 procedure codes in 2024, for 116 Medicare patients. Medicare paid $57,895 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 116 Medicare patients who saw Dr. Khil in 2024. The largest group is 65 to 74, with 57 patients. 75% of them have cancer, and 75% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Khil's median patient age at 76, with 44% women.

In 2024, Dr. Khil wrote 69 Medicare Part D claims for 33 patients. 72% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $275 in total drug cost. In 2022, CMS named 12 claims across 1 drug.

Dr. Khil accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 28 general payments to Dr. Khil from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 74% of the total. Elekta, Inc. paid the most, $200.